Literature DB >> 3664511

Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer.

D Zhou1, H Battifora, J Yokota, T Yamamoto, M J Cline.   

Abstract

Amplification of c-erbB-2 was at least three times more frequent in breast cancer than in most other types of carcinoma, and was not found in sarcomas or hematological malignancies. Amplification of c-erbB-2 was found in 15 of 86 primary breast cancers and in 3 of 12 secondary breast cancers. Amplification was more common in breast tumors of advanced stage, and in tumors which had metastasized to regional lymph nodes sites. Gene amplification was observed in 21% (4 of 19) of primary tumors which recurred within 3 years of mastectomy and in 6% (2 of 32) of nonrecurrent tumors.

Entities:  

Mesh:

Year:  1987        PMID: 3664511

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

Review 1.  Resistance of tumor cells to tumor necrosis factor.

Authors:  H M Shepard; G D Lewis
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

Review 2.  Developments in therapy with monoclonal antibodies and related proteins.

Authors:  H Michael Shepard; Gail Lewis Phillips; Christopher D Thanos; Marc Feldmann
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

3.  Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.

Authors:  N E Hynes; D Taverna; I M Harwerth; F Ciardiello; D S Salomon; T Yamamoto; B Groner
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma.

Authors:  K Tauchi; S Hori; H Itoh; R Y Osamura; Y Tokuda; T Tajima
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  c-erB-2 oncoprotein expression in malignant and nonmalignant breast tissue.

Authors:  A McCann; P A Johnston; P A Dervan; W J Gullick; D N Carney
Journal:  Ir J Med Sci       Date:  1989-06       Impact factor: 1.568

Review 6.  The neu-protein and breast cancer.

Authors:  C R De Potter; A M Schelfhout
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

8.  Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.

Authors:  G D Lewis; I Figari; B Fendly; W L Wong; P Carter; C Gorman; H M Shepard
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

9.  The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer.

Authors:  I Brotherick; B K Shenton; W K Cowan; B Angus; C H Horne; M J Higgs; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

10.  Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior.

Authors:  S S Bacus; C R Zelnick; D M Chin; Y Yarden; D B Kaminsky; J Bennington; D Wen; J N Marcus; D L Page
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.